GlucoTrack Inc/$GCTK
1D1W1MYTD1Y5YMAX
About GlucoTrack Inc
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
- Ticker
- $GCTK
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 15
- Headquarters
- Rutherford, United States
- Website
- glucotrack.com
GlucoTrack Inc Metrics
BasicAdvanced
$1.8M
-
-$7.52
-
-
Price and volume
Market cap
$1.8M
52-week high
$14.14
52-week low
$0.25
Average daily volume
17M
Financial strength
Current ratio
0.462
Quick ratio
0.376
Long term debt to equity
-14.245
Total debt to equity
-112.522
Interest coverage (TTM)
-270.16%
Profitability
EBITDA (TTM)
-15.333
Management effectiveness
Return on assets (TTM)
-164.45%
Return on equity (TTM)
-620.63%
Valuation
Price to book
-1.01
Price to tangible book (TTM)
-1.01
Price to free cash flow (TTM)
-0.037
Free cash flow yield (TTM)
-2,727.02%
Free cash flow per share (TTM)
-7.689
Growth
Earnings per share change (TTM)
-95.23%
GlucoTrack Inc News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.